Cargando…
c-erbB-2 oncoprotein detected by automated quantitative immunocytochemistry in breast carcinomas correlates with patients' overall and disease-free survival.
The prognostic significance of c-erbB-2 oncoprotein overexpression detected in tumours by immunocytochemical assays (ICAs) was investigated in 148 breast carcinomas. ICAs were performed under optimal technical conditions with frozen tissue sections and included automated immunoperoxidase technique a...
Autores principales: | Charpin, C., Garcia, S., Bouvier, C., Martini, F., Lavaut, M. N., Allasia, C., Bonnier, P., Andrac, L. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1997
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2223535/ https://www.ncbi.nlm.nih.gov/pubmed/9184184 |
Ejemplares similares
-
Automated and quantitative immunocytochemical assays of Bcl-2 protein in breast carcinomas.
por: Charpin, C., et al.
Publicado: (1997) -
Quantitative immunohistochemical expression of c Kit in breast carcinomas is predictive of patients' outcome
por: Charpin, C, et al.
Publicado: (2009) -
c-Met overexpression in inflammatory breast carcinomas: automated quantification on tissue microarrays
por: Garcia, S, et al.
Publicado: (2007) -
Prediction of metastasis risk (11 year follow-up) using VEGF-R1, VEGF-R2, Tie-2/Tek and CD105 expression in breast cancer (n=905)
por: Dales, J P, et al.
Publicado: (2004) -
VLA2 integrin expression in breast carcinomas evaluated by automated and quantitative immunohistochemistry.
por: Charpin, C., et al.
Publicado: (1998)